Application and Validation of SARS-CoV-2 RBD Neutralizing ELISA Assay
SARS-CoV-2 RBD 중화 ELISA 분석의 적용 및 검증
Article
[키워드] 95% CI
absorbance
acute respiratory syndrome
acute respiratory syndrome coronavirus
angiotensin
Angiotensin-converting enzyme
anti-RBD
anti-SARS-CoV-2 IgG
antibody
application
approach
biosafety
clinical evaluation
Coefficient of determination
Cohort
Concentration
convalescent
convalescent plasma
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
correlation
COVID-19
COVID-19 patients
COVID-19 vaccine
COVID-19 vaccines
demonstrated
detect
different time point
different time points
disease severity
domain
Donor
Efficiency
ELISA
ELISA assay
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
gold
gold standard
healthy individual
healthy individuals
host cell
host cell receptor
house
human Angiotensin-converting enzyme
individual
Interaction
Laboratory
Live virus
live viruses
log
methodology
NAb
NAbs
nAbs.
Neutralizing
Neutralizing antibodies
neutralizing antibody
optical
optical density
pandemic
processed
Protein
purified
Quantitative
RBD
respiratory
Safe
SARS-CoV-2
SARS-CoV-2 nAbs
SARS-CoV-2 RBD
SARS-COV-2-RBD neutralizing ELISA assay
sensitivity
Seroprevalence
serum sample
serum samples
specificity
Spike protein
standard curve
statistical
the spike protein
Treatment
treatment of COVID-19 patients
validation
viruses
[DOI] 10.22092/ARI.2021.356677.1890 PMC 바로가기 [Article Type] Article
[DOI] 10.22092/ARI.2021.356677.1890 PMC 바로가기 [Article Type] Article